Acquisition - March 12, 2015
AstraZeneca Buys More Respiratory Business
AstraZeneca recently acquired the rights to Actavis’ branded respiratory business in the US and Canada, according to a company announcement. As part of the agreement, AstraZeneca is paying Actavis $600 million of initial consideration and agreed to pay low single-digit royalties above a certain revenue threshold. AstraZeneca also paid Actavis an additional $100 million for […]
Collaboration - March 12, 2015
Artists, Scientists Share Space
Swedish artists and scientists are forming a community through the Artreslab project, taking shape in the Haga district linking Stockholm and Solna. One aim of the project is to explore the boundaries and build bridges between scientific and artistic research, says Elisabeth Wade, head of the art Division at the Stockholm County Council’s Culture Committee. […]
Uncategorized - March 12, 2015
Too Much Vitamin D Poses Risk
A study done at the University of Copenhagen is the first in the world to show a connection between high levels of vitamin D in the blood and cardiovascular deaths. Higher levels of the vitamin were associated with an increased risk of dying from a stroke or a coronary. “If your vitamin D level is […]
Pharma Business - March 11, 2015
Recipharm Creates New Position
Recipharm has appointed Thomas Beck to a new position, vice president, quality management, effective April 1, 2015. Since 2010 Beck has been head of quality control and assurance – quality manager for Recipharm. He is also president of the pharmaceutical section for quality assurance. Beck’s duties will include leading and coordinating quality strategy and policy […]
Companies - March 11, 2015
SARomics Opens US Sales Office
SARomics Biostructures has opened a sales office in Cambridge, Massachusetts, in the U.S. “We are excited about the move to this vibrant area and look forward to get the opportunity to work with world-class companies and their ground breaking projects,” says Björn Walse, CEO of SARomics Biostructures, whose headquarters is in the Medicon Valley region […]
In a new job - March 11, 2015
New CEO for Vivo Line Medical
Patrick Greatrex has been appointed the new CEO of Medtech company Vivo Line Medical, taking office March 9. He succeeds Peter Sebelius. Previously Greatrex was CEO of CMC Contrast, CEO of Combigene and vice president of Glycorex Transplantation. He also worked on business development for Gambro. Peter Sebelius did not leave the company, but is […]
